期刊文献+

386株铜绿假单胞菌的耐药性研究

下载PDF
导出
摘要 目的:为了解铜绿假单胞菌在本院的耐药情况,指导临床合理用药。方法:对2000年1月~2005年6月临床分离的386株铜绿假单胞菌进行耐药性分析。结果:铜绿假单胞菌多源于下呼吸道和伤口感染。铜绿假单胞菌对亚胺培南的耐药率最低,为7.5%,其次为头孢吡肟为7.9%;阿米卡星为8.7%;头孢哌酮/舒巴坦为9.4%。头孢他啶为9.5%。其他抗生素也有不同程度的耐药率,且出现多重耐药菌株。结论:铜绿假单胞菌在临床感染中占有非常重要的地位。
作者 隋达伟 徐艳
机构地区 长春市中心医院
出处 《吉林医学》 CAS 2005年第10期1089-1089,共1页 Jilin Medical Journal
  • 相关文献

参考文献5

二级参考文献37

  • 1秦俊玲,韩呈武,王素兰,李春英,王路,林桂秋.10年临床感染细菌的病原学与常用抗生素的调查分析[J].中华医院感染学杂志,1996,6(4):243-245. 被引量:59
  • 2[1]Bonfiglio G, Carciotto V, Russo G, et al. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey[J]. Antimicrob Chemother, 1998, 41(2): 307-310.
  • 3[2]Segatore B, Setacci D, Perilli M, et al. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1999, 43(2): 428-431.
  • 4[3]Jones RN, Beach ML, Pfaller MA. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different[J]. Diagn Microbiol Infect Dis, 2001, 41(3): 161-163.
  • 5[4]Kirby JT, Mutnick AH, Jones RN, et al. Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)[J]. Diagn Microbiol Infect Dis, 2002, 43(4): 303-309.
  • 6[5]Karlowsky JA, Kelly LJ, Thornsberry C, et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST (tracking resistance in the United States today) and TSN (the surveillance network) data for the United States[J]. Int J Antimicrob Agents, 2002, 19(1): 21-31.
  • 7[6]Sheng WH, Chen YC, Wang JT, et al. Emerging fluoro-quinolone-resistance for common clinically important Gram-negative bacteria in Taiwan[J]. Diagn Microbiol Infect Dis, 2002, 43(2): 141-147.
  • 8[7]Bhavnani SM, Callen WA, Forrest A, et al. Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals[J]. Am J Health-System Pharm, 2003, 60(19): 1962-1970.
  • 9[8]Kukeishi A, Diver JM, Beckthold B, et al. Cloning and nucleotide sequence of P. aeruginosa gyr A gene from PA01 and quinolone-resistant clinical isolates[J]. Antimicrob Agents Chemother, 1994, 38(9): 1944-1952.
  • 10[9]Yonezawa M, Takahata M, Matsubara N, et al. DNA gyrase gyr A mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1995, 39(9): 1970-1972.

共引文献189

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部